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Abstract
MEN2A is a hereditary syndrome characterized by medullary thyroid carcinoma, hyperparathyroidism, and
pheochromocytoma. Classically patients with a pheochromocytoma initially present with the triad of paroxysmal
headaches, palpitations, and diaphoresis accompanied by marked hypertension. However, although reported as a
rare presentation, spontaneous hemorrhage within a pheochromocytoma can present as an abdominal
catastrophe. Unrecognized, this transformation can rapidly result in death. We report the only documented case of
a thirty eight year old gentleman with MEN2A who presented to a community hospital with hemorrhagic shock
and peritonitis secondary to an unrecognized hemorrhagic pheochromocytoma. The clinical course is notable for
an inability to localize the source of hemorrhage during an initial damage control laparotomy that stabilized the
patient sufficiently to allow emergent transfer to our facility, re-exploration for continued hemorrhage and
abdominal compartment syndrome, and ultimately angiographic embolization of the left adrenal artery for control
of the bleeding. Following recovery from his critical illness and appropriate medical management for
pheochromocytoma, he returned for interval bilateral adrenal gland resection, from which his recovery was
unremarkable. Our review of the literature highlights the high mortality associated with the undertaking of an
operative intervention in the face of an unrecognized functional pheochromocytoma. This reinforces the need for
maintaining a high index of suspicion for pheochromocytoma in similar cases. Our case also demonstrates the
need for a mutimodal treatment approach that will often be required in these cases.
Background
Multiple endocrine neoplasia 2A (MEN2A) is a rare
autosomal dominant syndrome caused by missense
mutations in the RET proto-oncogene associated with
medullary thyroid cancer, pheochromocytoma and
hyperparathyroidism. Pheochromocytoma is a rare cate-
cholamine-secreting tumor of the adrenal glands most
often presenting with the characteristic symptoms of
paroxysmal hypertension, palpitations, diaphoresis, and
headache. Acute onset abdominal pain and nausea may
be the only presenting symptoms of spontaneous intra-
abdominal hemorrhage, a rare and highly lethal compli-
cation. We present a case of spontaneous intra-abdom-
inal hemorrhage secondary to a ruptured
pheochromocytoma, subsequent management, and a
review of the literature.
Case Presentation
M.J., a 38-year-old man developed sudden severe
abdominal pain, nausea, and vomiting after shoveling
snow. Prior to this event, he denies having had any epi-
sodes of hypertension, tachycardia or diaphoresis,
although several months prior he was diagnosed with
essential hypertension and was started on lisinopril. In
addition, he denied any recent abdominal or flank
trauma. Of note, his past medical history is significant
for a diagnosis of MEN2A which was made at the age of
18 months, and a prophylactic total thyroidectomy at
age 10 secondary to elevated serum calcitonin levels.
Since that time he has had no further follow-up,
although of his two children, his daughter has been
diagnosed with MEN2A and undergone a prophylactic
total thyroidectomy 2 years prior to this event. On
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phoretic with a heart rate of 180 bpm and systolic blood
pressure of 64 mmHg. Fluid resuscitation was initiated
and the patient was taken to an outside hospital. Initial
evaluation at the local level II trauma center was notable
for a heart rate of 150 bpm, systolic blood pressure of
70 mmHg, diffuse peritoneal signs, a hematocrit of 34%,
INR of 1.0 and PTT of 30.4. Following resuscitation
with additional crystalloid and 2 units of packed red
blood cells (pRBC), his hematocrit was 34%, INR 2.4
and PTT 66.2. A non-contrast abdominal computed
tomogram revealed bilateral adrenal masses and a large
amount of intra and retroperitoneal hemorrhage (Figure
1). In light of his hemodynamic instability and CT find-
ings, emergent laparotomy was undertaken. Upon enter-
ing the abdomen, a large amount of blood was
encountered and immediate control of the abdominal
aorta was obtained to manage the ongoing hemorrhage
and facilitate resuscitation which ultimately required 12
units of pRBCs, 4 units of fresh frozen plasma (FFP)
and 6 units of platelets. A bleeding source was identified
in the left upper quadrant (LUQ) in the retroperitoneal
fat which was oversewn. The abdomen was packed with
laparotomy pads and closed; the blood loss was esti-
mated to be 8000 cc.
The patient was subsequently transferred to our facil-
ity for further care. On arrival he was intubated and
sedated with a blood pressure of 90/35 mmHg, heart
rate 129 bpm, Hct 36.3%, INR 2.7 and fibrinogen 117
mg/dL. On initial examination his abdomen was tense
and distended, and his extremities were cold. Ongoing
hemorrhage was suspected given the coagulopathy and
persistent hypotension, therefore aggressive resuscitation
with blood products was resumed. An initial bladder
pressure of 33 mmHg along with poor urine output,
hypotension and a tense abdominal examination raised
suspicion for an evolving abdominal compartment syn-
drome; therefore a second emergent exploration was
undertaken. On entry into the abdominal cavity, the
right colon was found to be frankly ischemic and persis-
tent hemorrhage from the LUQ was again noted. As the
source of bleeding could not be readily identified, an
emergent splenectomy was performed, and laparotomy
pads were again packed into the LUQ. Once adequate
control of the bleeding was obtained with packing,
attention was turned to performing a right hemicolect-
omy. A Bogota bag with a wound V.A.C (KCI, TX) was
then fashioned for temporary abdominal closure. Fol-
lowing closure of the abdomen, the patient suffered car-
diac arrest with pulseless electrical activity. Advanced
cardiac life support measures were initiated and a per-
fusing rhythm was obtained shortly thereafter. Given the
history of MEN2A and bilateral adrenal masses, the
diagnosis of occult pheochromocytoma was entertained.
The blood pressure swings were controlled with phento-
lamine and a sodium nitroprusside infusion with good
effect. The patient was returned to the surgical intensive
care unit for further management.
In the intensive care unit, the patient continued to
have a labile blood pressure, a persistent base deficit,
decreasing hematocrit and drainage of large amount of
blood from the VAC, therefore he was emergently taken
to interventional radiology. Diagnostic angiography
revealed contrast extravasation from the left adrenal
artery which was embolized with 250 micron Embo-
zene™ (CeloNova BioSciences, GA) microspheres and
Gelfoam™ (Pfizer, NY) slurry to good effect (Figure 2).
In addition, extravasation from a left intercostal artery
was also controlled with embolization. Although no
active extravasation was noted from the transected end
of the splenic artery, embolization was performed for
additional security. Following this procedure, the
patient’s Hct stabilized and no further significant
hemorrhage was encountered throughout the rest of his
admission. Subsequently, a continuous infusion of
sodium nitroprusside was required to mange the malig-
nant hypertension. On post-operative day three, treat-
ment with phenoxybenzamine was started for a-
adrenergic blockade.
Serum metanephrines and normetanephrines levels
w e r ef o u n dt ob em a r k e d l ye l e v a t e da t1 4 . 0n m o l / L
(reference range 0.00-0.49) and 24.3 nmol/L (reference
range 0.0-0.89) respectively. Thereafter, his recovery was
relatively unremarkable; he underwent two additional
procedures to restore bowel continuity and for abdom-
inal wall closure. He was discharged in good condition
Figure 1 CT scan of the abdomen with left adrenal mass (white
arrow) and associated intra-peritoneal hemorrhage (black
arrow) obtained on presentation to the outside hospital.
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instructions to continue taking phenoxybenzamine and
labetolol. He returned after approximately 4.5 months
for a bilateral retroperitoneoscopic adrenalectomy. Of
note, intra-operatively, scarring and adhesions were
noted between the left adrenal gland and surrounding
periadrenal and perirenal fat. Final pathologic examina-
t i o nr e v e a l e da5c mr i g h ta n d4c mb i - l o b e dl e f ta d r e -
nal (Figure 3) pheochromocytomas without evidence of
definite vascular invasion or extension beyond either
gland. He has since been seen in clinic for routine fol-
low-up, and found to be recovering well, requiring labte-
lol 100 mg PO bid for adequate blood pressure control.
He is currently taking hydrocortisone, 10 mg bid for
steroid replacement.
Discussion
Multiple endocrine neoplasia type 2A (MEN2A) or Sip-
ple Syndrome is an autosomal dominant syndrome, first
described by Sipple [1] and later characterized in multi-
ple kindreds by Schimke [2], caused by misense muta-
tions in the RET protooncogene [3,4], a tyrosine kinase
receptor. MEN2A is characterized by the early develop-
ment of medullary thyroid cancer, and later develop-
ment of pheochromocytoma and primary
hyperparathyroidism. The estimated prevalence of
MEN2A is 2.5 per 100,000 [5] of which approximately
5-9% are sporadic and paternal in origin [6]. The inci-
dence of pheochromocytoma in MEN2A kindreds is
approximately 40-50%, with an average age of diagnosis
between 30-40 years [7]. Although pheochromocytoma
is traditionally referred to as the “10% tumor” (10%
being bilateral, malignant, extra-adrenal, hereditary, aris-
ing in children), in MEN2A patients, approximately 68%
will have bilateral involvement with malignant disease
occurring in 4% of cases [8].
Pheochromocytomas are rare, catecholamine secreting,
yellowish-brown tumors composed of chromaffin cells
derived from embryonic neural crest cells which were
first described by Frankel [9] in 1886 in a young woman
likely afflicted with MEN2 [10]. Hereditary causes
account for 20% of cases, while sporadic cases occur with
an estimated prevalence of 0.95 per 100,000 adults per
year [11]. In addition to MEN2, von Hippel Lindau Type
a.                    b. 
Figure 2 Embolization of left adrenal artery and left T11 posterior intercostal artery.a .P r e - e m b o l i z a t i o n .T h ew h i t ea r r o wi n d i c a t e sa
retained laparotomy pad. The coils seen left of center were previously deployed in the splenic artery stump. Black arrow #1 denotes contrast
extravasation from the left adrenal artery. Black arrow #2 denotes contrast extravasation from the left posterior intercostal artery. b. Post-
emboization. No further contrast extravasation was observed following embolization of both vessels with 250 micron Embozene™ (CeloNova
BioSciences, GA) microspheres and Gelfoam™ (Pfizer, NY) slurry.
Figure 3 Representative photograph of the left adrenal gland
with a medullary mass and associated peri-adrenal fat.
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familial paragangliomas are associated with the develop-
ment of pheochromocytomas. Eighty percent of all pheo-
chromocytomas arise within the adrenal medulla, while
extra-adrenal lesions are most commonly found in the
sympathetic ganglia as well as the organs of Zuckerkandl.
Of note, it is estimated that 5% of adrenal incidentalomas
are likely pheochromocytomas [12]. In addition to secret-
ing the catecholes dopamine, epinephrine and norepi-
nephrine, numerous other hormones have been isolated
from pheochromocytomas including adrenocorticotropin,
vasoactive intestinal peptide, neuropeptide Y, IL-6, calci-
tonin, and chromogranin A.
Classically patients initially present with the triad of
paroxysmal headaches, palpitations, and diaphoresis
accompanied by marked hypertension. Of interest, it is
estimated that pheochromocytomas are present in 0.1-
0.6% of patients with hypertension [13]. In addition to
these symptoms, pallor, nausea, flushing, anxiety or a
sense of doom, palpitations and abdominal pain can be
part of the constellation of presenting symptoms. More
ominously, patients may present in fulminant cardio-
genic shock [14], multiorgan failure, or with acute
hemorrhage. Several biochemical assays are available to
facilitate diagnosis, however, plasma free metanephrines
had the highest sensitivity and urinary VMA had the
highest specificity in a recent multicenter cohort trial
[15] in the detection of pheochromocytomas. Once bio-
chemical evidence of pheochromocytoma is obtained,
imaging for localization should be undertaken to guide
surgical resection. Computed tomography and magnetic
resonance imaging provides high sensitivity for lesion
detection, though poor specificity. Alternative imaging
modalities such as I
123 or I
131 MIBG scintigraphy or
PET may be utilized when CT or MRI fail to reveal the
lesion or if malignancy is suspected.
Although both Roux (Switzerland) and Mayo (US) are
credited with concomitantly performing the first suc-
cessful resections of pheochromocytomas in 1926,
neither described any peri-operative hemodynamic
instability, and both patients survived [16]. However, in
the ensuing years, further attempts at resection were
met with a mortality rate of approximately 25%. It was
not until 1956 when Priestley recorded a case series of
51 patients who underwent resection without any
deaths. His success is attributable to the use of phento-
lamine and norepinephrine to manage the hemodynamic
instability that is typically encountered [16]. Lessons
learned during the early years of surgical management
have led to the recognition of the importance of initial
peri-operative a-blockade and volume expansion fol-
lowed by b-blockade for management of tachycardia
and hypertension in anticipation of elective surgical
resection.
Implementation of these management principles in the
emergent setting can often be challenging as patient
presentation can be widely variable, ranging from minor
retroperitoneal hemorrhage with hypertension or
abdominal pain to shock and impending cardiovascular
collapse. In the setting of a contained retroperitoneal
hemorrhage, every effort should be made to avoid emer-
gent or urgent surgical intervention. Not surprisingly,
review of the literature reveals a mortality of ~25% asso-
ciated with emergent surgical intervention for contained
hemorrhage; in contrast, adequate medical preparation
as described above results in a mortality rate similar to
that observed for elective adrenalectomy in the absence
of hemorrhage. Medical optimization should include
adequate blood resuscitation, correction of any coagulo-
pathy to limit continued hemorrhage, hemodynamic
support as needed, and ultimately a-blockade followed
by volume expansion and b-blockade in an in-patient
setting. This simplistic algorithm must be tempered by
the recognition that providing supportive care in the
setting of cardiovascular collapse mediated by adrenal
compression from an evolving retroperitoneal hematoma
and the resulting catecholamine excess may tax even the
most advanced intensive care unit. Emergent surgical
intervention may be considered in cases refractory to
maximal medical management as recently described by
May and colleagues [17] with recognition of the atten-
dant high morbidity and mortality.
Spontaneous hemorrhage within a pheochromocytoma
resulting in capsular rupture and retroperitoneal or
intra-peritoneal hemorrhage has long been recognized
as a rare, but catastrophic and highly lethal event. In
addition, trauma [17] and medications [18,19] have also
been implicated in hemorrhagic complications. In a
review of the literature, we have identified 49 documen-
ted cases between 1944 and 2010 [14,17-52] of which,
including this report, 12 involved spontaneous intra-
peritoneal hemorrhage [19,53-61] (Table 1). Review of
these twelve cases revealed that emergent laparotomy
resulted in a mortality of 29%, consistent with the mor-
tality observed prior to the routine use of pre-operative
a-adrenergic blockade [16]. More telling is the 100%
mortality associated with misdiagnosis and failure to
control the hemorrhage in a timely fashion. Though the
case number is small, these data suggest that although
undertaking an emergent exploration for this indication
is fraught with danger, it offers the patient the best
opportunity for survival. In the absence of adequate a-
adrenergic blockade in these extreme cases, the intra-
operative and post-operative care must be tailored to
the clinical picture as it evolves. Thus, the anaesthesia
and surgical teams must be prepared to manage sudden
cardiovascular collapse, fulminant heart failure, massive
pulmonary edema, and ongoing hemorrhage. Immediate
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tic counter-pulsation pump, a percutaneous right ventri-
cular assist device, a ventilator capable of maintaining
high positive end-expiratory pressures with advanced
ventilation modes (ex. APRV, BiLevel), an established
massive transfusion protocol, and interventional radiolo-
gists are vital in the successful management of these
challenging cases. If the tumor is completely removed,
post-operative a-blockade is not typically necessary;
however, if transcatheter arterial embolization (TAE) is
used as a temporizing measure, continued a-blockade
becomes essential as discussed below.
In the present case, we were faced with a unique set of
circumstances which dictated an unconventional course
of management. Although the patient’sm e d i c a lh i s t o r y
notable for total thyroidectomy as a child and the pre-
sence of the bilateral adrenal masses raised suspicion for
MEN2A and possible pheochromocytoma, given his
initial presentation in extremis with hemoperitoneum the
decision to undertake an emergent exploratory laparot-
omy was warranted. Although only partial control of the
hemorrhage was obtained at that time, it should be
stressed that inaction may have resulted in this patient’s
demise given the historically observed 100% mortality in
the face of conservatively managed intra-peritoneal
hemorrhage from pheochromocytoma. Upon arrival to
our facility, we were faced with an evolving abdominal
compartment syndrome in addition to acute hemorrhage
of unclear etiology. In the course of the second laparot-
omy, hemodynamic instability, the need to address the
sequelae of abdominal hypertension, and worsening coa-
gulopathy precluded further exploration of the LUQ for
the continued source of hemorrhage. Moreover, given
the presence of bilateral adrenal masses in the setting of
a history of MEN2A, further exploration of the adrenals
without proper a-blockade presented addition significant
risk of morbidity and mortality. Therefore the decision
was made to proceed with angiographic embolization in
the setting of continued bleeding.
TAE as a therapeutic option for pheochromocytoma
was first described in 1978 by Bunuan [62] and colle-
gues. Their effort to use gel foam TAE was met with
significant hemodynamic instability resulting in emer-
gent laparotomy for excision of the necrotic tumor.
Since this initial experience, TAE has been reported in
the literature as a palliative option in the management
of malignant pheochromocytoma when surgical extirpa-
tion is not feasible [63,64]. More germane to the present
case, the use of TAE for management of acute sponta-
neous intraperitoneal hemorrhage from a pheochromo-
cytoma has not been previously reported, although its
use in retroperitoneal hemorrhage as been described by
t w os e p a r a t eg r o u p s[ 1 7 , 5 0 ] .I nt h ep r e s e n tc a s ea n y
further effort to explore the LUQ for the source of
hemorrhage may very well have resulted in the patient’s
demise. We therefore elected to salvage the situation by
employing damage control techniques to quickly get the
patient out of the operating room to facilitate TAE of
the suspected hemorrhaging pheochromocytoma. Inter-
estingly, in addition to embolization of a left adrenal
artery in this case, a bleeding left intercostal artery was
also identified. In an effort to better define the anatomy
of the suprarenal arteries, Toni and colleagues reviewed
aortography performed on patients without known
suprarenal disease [65]. They identified the origin of the
left suprarenal artery as a left intercostal branch in 3%
of the patients in their study. As described in all of
these reports, post-TAE hypertension can present a for-
midable challenge. In this case, malignant hypertension
was successfully managed with infusion of sodium nitro-
prusside in the acute setting, followed by administration
of phenoxybenzamine.
Table 1 Features of previously reported pheochromocytomas complicated by intra-peritoneal hemorrhage
Pt Symptoms Dx
Known
Intervention Outcome
Hanna 2010 38M Shock, abdominal pain No Emergent exploration alive
Li 2009 50M HTN, abdominal pain, palpable mass No Delayed exploration alive
Chan 2003 35F abdominal pain No Emergent exploration dead
Lee 1987 31M abdominal pain, orthostasis No Emergent exploration alive
Greatorex 1984 46M HTN, CP, palpitation, HA, emesis, tachychardia No Emergent exploration alive
Wenisch 1982 62F abdominal pain, nausea, palpable mass No Emergent exploration alive
Bednarski 1981 69M abdominal pain, dyspnea No None dead
van Royen 1978 53M HTN, abdominal pain, palpable mass, bronchospasm No None dead
Van Way 1976 76F HTN, abdominal pain Yes Emergent exploration alive
Gielchinsky 1972 36M abdominal pain, peritonitis Yes Delayed exploration alive
Cahill 1944 53F abdominal pain No Emergent exploration dead
61 shock, sudden death No None dead
A summary of the 11 previously described cases of ruptured pheochromocytoma with free intraperitoneal hemorrhage including the present case. The relevant
symptoms on presentation, timing of operative intervention and outcome are summarized.
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Spontaneous intraperitoneal hemorrhage remains a rare
complication of pheochromocytoma, though the physio-
logic consequences present considerable medical and
surgical challenges. Unfortunately, the resulting emer-
gent clinical scenario does not allow for optimal pre-
operative medical preparation with a-adrenergic block-
ade, and as such is associated with a high mortality.
The present case has demonstrated the importance of
multi-modal therapy including the need for emergent
surgical intervention and the availability of interven-
tional radiology for control of the hemorrhage. Most
importantly, a high index of suspicion must be main-
tained in similar cases so that the highly lethal hemody-
namic sequelae may be anticipated and managed with
the appropriate pharmacologic agents to ensure optimal
outcomes.
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